Hymon - Respiratory Triplex Panel Test Kit
From Test Kit
Hymon Respiratory Triplex Panel Test Kit applies innovative “one-step method” to solve the cumbersome problem of nucleic acid extraction for SARS-CoV-2, influenza A and influenza B viruses; The nucleic acid is automatically released in 3 minutes, with sample-to-results as short as 35 minutes. Based on MoLock (nano-antibody molecular lock technology) and dual internal standard design, it achieves high sensitivity, high specificity, and full-process monitoring. A single tube can help detect COVID-19 N and E genes, influenza A and influenza B viruses by multiplex testing.
-
Most popular related searches
Advantages
Rapid detection
Simultaneous detection of all three pathogens completed with an innovative and exclusive one-step method. RNA processing completed in 3 minutes, with sample-to-results in 35 minutes.
One-tube multiplex testing
A single tube can help detect COVID-19 N and E genes, influenza A and influenza B viruses.
Accurate and safe
Full coverage of genes, multiplex detection, and multiple guarantees, among which the SARS-CoV-2 test has been approved by the FDA.
Multiple monitoring
Operation quality control includes three internal standards: positive control, negative control, and human DNA gene sequence.
Unique technology
Nanobody molecular locking technology (MoLock) improves sensitivity and specificity.
High sensitivity
Sensitivity reaches 5 copies/reaction.
CE Certification
Clinical Application
The Respiratory Triplex Panel Test Kit for COVID-19 and influenza A/B detects multiple pathogens in one tube, accurately distinguishes COVID-19 from HBV viruses, assists doctors in diagnosing disease, and provide a reliable basis for epidemic prevention and control and clinical treatment.
Customer reviews
No reviews were found for Hymon - Respiratory Triplex Panel Test Kit. Be the first to review!